8th Asian Biosimilars Congress
- Start Date:
- Thursday, 10 August, 2017
- End Date:
- Saturday, 12 August, 2017 5:00pm
- Health & Nutrition
Biosimilars Asia 2017 is a specially designed cluster conference. The main theme of the conference is "Biosimilars-Uncovering An Innovation In Motion" which covers a wide range of critically important sessions. All over the world, there are more than 380 companies producing Biologics and Biosimilars and 55,000 industrialists doing their research work. The global Biosimilars market (Follow-On-Biologics) is expected to reach $26.5Billion by 2020 growing at a CAGR of 49.1% from 2015 to 2020 whereas the global biosimilars market alone is expected to reach $6.22 Billion by 2020 from $2.29 Billion in 2015, at a compound annual growth rate (CAGR) of 22.1% from 2015 to 2020.
There are currently more biosimilar products in development across the Asia-Pacific region than anywhere else in the world, leading to a wealth of opportunities for investigators and patients to take part in biosimilar clinical trials. Countries in Asia, particularly India, Singapore, Korea, Japan and China, are the attractive locations to build bio development and bio manufacturing capabilities.Conference Highlights:Latest Biosimilars in Asian ScenarioBiosimilars- Hatch-Waxman Act & BPCI ActChallenges in Developing BiosimilarsBiosimilars Research PipelineCurrent Developments in The Field of BiosimilarsPharmacovigilance of BiosimilarsEmerging Trends in BiosimilarsBiosimilars Market- Challenges & ProspectsCost Analysis of BiosimilarsGlobalization of BiosimilarsBiosimilars Analytical StrategiesEmerging Biosimilars in TherapeuticsClinical Studies on BiosimilarsBCS & IVIVC Based BiowaiversEntrepreneurs Investment Meet
Conference organized by conference series LLC
Neurology is the study of injuries, disorders, diagnosis and treatment of thebrain, spine and nervoussystem including their coverings, blood vessels, and all effector tissues. There More than 600 known neurological disorders are there which affects our nervous system severely but still for most of the diseases treatment options are very limited and research is going on.
- JW Marriott Dubai